Cargando…
Digoxin Inhibits Induction of Experimental Autoimmune Uveitis in Mice, but Causes Severe Retinal Degeneration
PURPOSE: Digoxin, a major medication for heart disease, was recently reported to have immunosuppressive capacity. Here, we determined the immunosuppressive capacity of digoxin on the development of experimental autoimmune uveitis (EAU) and on related immune responses. METHODS: The B10.A mice were im...
Autores principales: | Hinshaw, Samuel J. H., Ogbeifun, Osato, Wandu, Wambui S., Lyu, Cancan, Shi, Guangpu, Li, Yichao, Qian, Haohua, Gery, Igal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821074/ https://www.ncbi.nlm.nih.gov/pubmed/27028065 http://dx.doi.org/10.1167/iovs.15-19040 |
Ejemplares similares
-
Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response
por: Wandu, Wambui S., et al.
Publicado: (2015) -
Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells
por: Bing, So Jin, et al.
Publicado: (2020) -
Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune Uveitis
por: Xu, Biying, et al.
Publicado: (2021) -
SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU)
por: Vistica, Barbara P., et al.
Publicado: (2012) -
Digoxin-induced retinal degeneration depends on rhodopsin
por: Landfried, Britta, et al.
Publicado: (2017)